相关实验视频
Updated: Sep 14, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.9K
喘恶化的危险因素
Lauri Nordman1, Iida Vähätalo1,2, Leena E Tuomisto1,2
1Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
The journal of allergy and clinical immunology. Global
|July 23, 2025
概括
成人发作的喘患者经常有多种恶化风险因素,最常见的是缺乏坚持,慢性鼻炎和吸烟. 胃食道逆流性疾病是这一群体中喘恶化的重要预测因素.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 流行病学 流行病学
背景情况:
- 成人发作的喘带来了复杂的挑战,通常涉及并发症.
- 成人发作的喘中恶化风险因素的患病率仍未得到充分研究.
- 全球喘倡议 (GINA) 的指导方针强调评估恶化风险因素.
研究的目的:
- 为了确定成人发作喘中恶化风险因素的患病率.
- 评估这些风险因素与喘恶化之间的关联.
- 根据2023年GINA报告评估风险因素.
主要方法:
- 对203名成人喘患者进行了为期12年的随访 (Seinäjoki成人喘研究).
- 对21个GINA定义的风险因素中的17个进行分析.
- 恶化被定义为因喘而未计划的医疗保健访问.
主要成果:
- 患者平均有3.8个恶化风险因素;常见的因素包括不良坚持 (54.7%),慢性鼻炎 (54.2%) 和吸烟 (52.7%).
- 胃食道逆流性疾病 (GERD) 和50岁以上的年龄在单变量分析中与恶化有关.
- 在调整后,只有GERD仍然是一个重要的风险因素 (OR,4.5;95% CI,1.5-14.0;P = .009).
结论:
- 在成人发作喘中,恶化风险因素很普遍.
- 识别单个风险因素可能具有有限的临床价值.
- 专注于患有多种风险因素和/或GERD的患者对于临床实践至关重要.
相关概念视频
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Asthma: Pathogenesis and Management
599
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
599
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
389
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
389

